Read this article in Français Deutsch Italiano Português Español
Novo Nordisk to spend $1.1bn to expand Brazilian plant
08 April 2025
Danish drug company Novo Nordisk has announced plans to invest 6.4 billion reais (US$1.1 billion) to expand production at a manufacturing plant in Brazil.
Image: REUTERS/Tom Little
The company said construction work has already started at the facility in Minas Gerais state for injectable drugs for the treatment of obesity and other chronic diseases.
Novo Nordisk chief executive Lars Fruergaard Jorgensen announced the investment at an event in the Minas Gerais city Montes Claros, according to Reuters.
The expanded facility will measure 74,000 square metres and is due for completion in 2028.
The factory will produce various products including semaglutide, the active ingredient in anti-obesity drugs Ozempic and Wegovy.
STAY CONNECTED
Receive the information you need when you need it through our world-leading magazines, newsletters and daily briefings.
CONNECT WITH THE TEAM
